MedAvail Holdings (STU:73M) Beta: 0.3872 (As of Jun. 26, 2026)


STU:73M MedAvail Holdings Inc STU:73M
12 GF Score
Price €11.05
View Full Analysis

What is MedAvail Holdings Beta?

MedAvail Holdings STU:73M 12 Beta is 0.3872 as of Jun. 26, 2026. GuruFocus rates STU:73M with a GF Score™ of 12/100.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), MedAvail Holdings's Beta is 0.3872.


MedAvail Holdings  (STU:73M) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


MedAvail Holdings Beta Related Terms


MedAvail Holdings Beta Historical Data

* Premium members only.

The historical data trend for MedAvail Holdings's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedAvail Holdings Beta Chart

MedAvail Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Beta
0.00 0.00 0.00 0.00

MedAvail Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

STU:73M vs HEWA, BIMI, MEDS: Beta Comparison

For the Pharmaceutical Retailers subindustry, MedAvail Holdings's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedAvail Holdings Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MedAvail Holdings's Beta distribution charts can be found below:

* The bar in red indicates where MedAvail Holdings's Beta falls into.


STU:73M
12GF Score
MedAvail Holdings Inc STU:73M
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MedAvail Holdings Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.3872 mean?
MedAvail Holdings (STU:73M) has a Beta of 0.3872 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for MedAvail Holdings and its competitors.
Is MedAvail Holdings' Beta too high?
MedAvail Holdings' current Beta is 0.3872. Overall, MedAvail Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does MedAvail Holdings' Beta compare to HEWA and BIMI?
MedAvail Holdings' Beta of 0.3872 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for MedAvail Holdings and its competitors. MedAvail Holdings's current Beta is 0.3872. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedAvail Holdings stock overvalued right now?
MedAvail Holdings (STU:73M) has a current Beta of 0.3872. The current Beta is 0.3872. MedAvail Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For MedAvail Holdings (STU:73M), the current Beta is 0.3872 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedAvail Holdings Business Description

Address 4720 East Cotton Gin Loop, Suite 220, Phoenix, AZ, USA, 85040
MedAvail Holdings Inc is a telehealth-enabled pharmacy technology company. It operates in two segments: Retail Pharmacy Services and Pharmacy Technology. It generates the majority of revenue from the Retail Pharmacy Services segment, which is into operating SpotRx, a full-service retail pharmacy utilizing MedAvail's automated pharmacy technology, servicing Medicare patients in the United States. The Pharmacy Technology segment develops and commercializes the MedCenter for direct sale or lease to third-party customers.
12GF Score

Get the complete analysis for STU:73M

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.05
Price